Association for the Advancement of Blood & Biotherapies

Jed_Gorlin

Dr. Jed B. Gorlin MD, MBA

Medical Director and Vice President, Quality and Regulatory Affairs, Co-Director, Transfusion Medicine, Associate Clinical Professor, Laboratory Medicine and Pediatrics, Innovative Blood Resources

Appearances

19EL-442 eCast On-Demand: Emergent Reversal of Anticoagulation Vitamin K Antagonist (VKA) and Direct Oral Anticoagulants (DOACs)
MN1-01: Evidence Based Approach to Newer Coagulation Products: Andexanet (anti-Xa agent reversal), Fibrinogen Concentrate & Freeze Dried Plasma
SN4-28: FDA Recommendations You Love to Hate: An Update on Babesia Testing and Bacterial Risk Control Strategies
ST2-15: Oral Abstract Session: Infectious Disease
TU2-18: Challenges and Opportunities for Developing and Implementing Global Transfusion Standards
AABB Annual Meeting Highlights 2020 Conference in the Middle East On-Demand: Hot Topic: Convalescent Plasma - International Perspectives
AM20-23: Does Assessing Vital Signs Contribute to Blood Donation Safety?
21EL-601 On-Demand Hot Topic Discussion: COVID-19 Vaccines, PrEP, MSM – What You Need to Know Heading Into 2021
Best Practices: Amazing Transfusion/Disaster Planning Simulations
AM21-28: Oral Abstract Session -- Blood Product Manufacturing and Storage
AM21-56: COVID-19 Convalescent Plasma: Impact on Donation Safety and Eligibility

Item	Price	Remove